COX-2 may be implicated in cancer development through several mechanisms: reducing apoptosis, increasing epithelial cell proliferation, promoting angiogenesis, and increasing invasiveness of tumor cells and immunosuppression [74–76]. This evidence concerns the gene PTGS2 and cancer.